treatment costs
TREATMENT COSTS OF PARKINSON’S DISEASE IN CENTRAL EUROPE
9
Treatment costs of psoriasis in a tertiary level clinic
6
The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer
8
Cost effectiveness analysis of insecticide treated net distribution as part of the Togo Integrated Child Health Campaign
7
A cost-effectiveness analysis of varenicline for smoking cessation using data from the EAGLES trial
8
The costs of traumatic brain injury due to motorcycle accidents in Hanoi, Vietnam
7
Costs and utilization of treatment in patients with hemophilia
7
Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma
8
Inpatient charges and mental illness: Findings from the Nationwide Inpatient Sample 1999–2007
10
A one-year prospective costing study of botulinum toxin type A treatment of chronic tension headache
5
The use of a standardized PCT-algorithm reduces costs in intensive care in septic patients - a DRG-based simulation model
6
Discussing patients’ insurance and out of pocket expenses during GPs’ consultations
7
Index Catalog // Carolina Digital Repository
276
Cost effectiveness of dihydroartemisinin piperaquine compared with artemether lumefantrine for treating uncomplicated malaria in children at a district hospital in Tanzania
13
Costs of HIV/AIDS treatment in Indonesia by time of treatment and stage of disease
12
Cost effectiveness of collaborative care for the treatment of major depressive disorder in primary care A systematic review
10
Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costs
6
AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub Saharan Africa: economic evaluation protocol for a randomised controlled trial based equivalence study
21
Cost of tumor necrosis factor blockers per patient with rheumatoid arthritis in a multistate Medicaid population
8
Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study
12